Chester County News and Community Website
WILMINGTON, DE — Incyte (Nasdaq: INCY) reported updated early-stage clinical trial data showing its experimental antibody INCA033989 produced rapid and durable responses in patients with myelofibrosis and essential thrombocythemia, supporting …
Incyte Antibody Shows Disease-Modifying Potential in Blood Cancers Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) reported Phase III trial results showing that adding tafasitamab and lenalidomide to the standard R-CHOP regimen reduced the risk of disease progression or death …
Incyte Trial Data Support New First-Line Approach in Lymphoma Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) has asked the U.S. Food and Drug Administration to grant Rare Pediatric Disease Designation for its experimental SkinJect therapy in patients with …
ICYMI: Medicus Seeks FDA Rare Disease Status for Skin Cancer Therapy Read More
NEWARK, DE — N-Zyme Biomedical has begun a Phase 2 clinical trial of its lead drug candidate for laryngopharyngeal reflux, advancing a treatment approach that targets pepsin rather than stomach …
N-Zyme Advances Pepsin-Targeting Reflux Drug Into Phase 2 Trial Read More
WEST CHESTER, PA — Molecular Targeting Technologies Inc. reported updated clinical data from 81 patients with gastroenteropancreatic neuroendocrine tumors treated with its experimental radiopharmaceutical EBTATE, results that the company says …
MTTI Reports Extended Disease Control Data in Neuroendocrine Tumor Study Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) reported four-year follow-up results from a first-in-human clinical study of its Freesolve resorbable magnesium coronary scaffold, providing long-term safety data as the company …
Teleflex Reports Four-Year Data for Resorbable Heart Scaffold Read More
NEWTOWN, PA — Traws Pharma Inc. (NASDAQ: TRAW) has deferred a planned Phase 2a human influenza challenge study of its lead antiviral candidate tivoxavir marboxil after receiving unfavorable feedback from …
Traws Delays Influenza Study After UK Regulatory Setback Read More PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has submitted an application to health regulators in Abu Dhabi to begin a genomics-based Phase 2a study of its investigational drug Teverelix …
Medicus Seeks UAE Approval for Genomics-Based Endometriosis Trial Read More
PHILADELPHIA, PA — Century Therapeutics (Nasdaq: IPSC) reported new preclinical data supporting its experimental type 1 diabetes therapy CNTY-813, as the biotechnology company works toward a planned Investigational New Drug …
Century Therapeutics Advances Diabetes Cell Therapy Toward 2026 FDA Filing Read More
WILMINGTON, DE — AstraZeneca reported updated Phase III trial results showing its investigational breast cancer therapy camizestrant extended the time patients lived without disease progression and delayed the need for …
AstraZeneca Breast Cancer Drug Extends Progression-Free Survival Read More